Effect of Simvastatin, an Established Lipid-Lowering Drug, on Pulmonary Chlamydia pneumoniae Infection in Mice
Open Access
- 1 September 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (9) , 3959-3962
- https://doi.org/10.1128/aac.49.9.3959-3962.2005
Abstract
The effects of simvastatin treatment on Chlamydia pneumoniae lung infection, inflammation, and serum lipids in mouse model were studied. Simvastatin decreased viable chlamydial counts and increased inflammatory cell infiltrates in the lung tissue, suggesting that simvastatin treatment had both antichlamydial and immunomodulatory effects during an acute C. pneumoniae infection.Keywords
This publication has 39 references indexed in Scilit:
- Statins Inhibit HIV-1 Infection by Down-regulating Rho ActivityThe Journal of Experimental Medicine, 2004
- Enhancing effect of dietary cholesterol and inhibitory effect of pravastatin on allergic pulmonary inflammationJournal of Biomedical Science, 2004
- HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of SepsisCirculation, 2004
- Hydroxymethyl-Glutaryl Coenzyme A Reductase Inhibition Limits Cytomegalovirus Infection in Human Endothelial CellsCirculation, 2004
- Salmonella enterica Serovar Typhimurium Requires Nonsterol Precursors of the Cholesterol Biosynthetic Pathway for Intracellular ProliferationInfection and Immunity, 2004
- Hydroxymethylglutaryl Coenzyme A Reductase Inhibition Reduces Chlamydia pneumoniae -Induced Cell Interaction and ActivationCirculation, 2003
- The Effect of Statins on Mortality in Patients with BacteremiaClinical Infectious Diseases, 2001
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994
- Vastatins inhibit cholesterol ester accumulation in human monocyte-derived macrophages.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Inhibition of Cholesterol Synthesis in vitro and in vivo by ML‐236A and ML‐236B, Competitive Inhibitors of 3‐Hydroxy‐3‐methylglutaryl‐Coenzyme A ReductaseEuropean Journal of Biochemistry, 1977